The fundamentals of the company haven't changed.
The cash position is strong (fully funded)
The drug clearly works, mountains of evidence, with a strong safety history.
Competent experienced management.
Massive future potential revenues with both application (OA, MPS).
The last few months is just the market doing its thing, no need for an exit plan IMO.
The fundamentals of the company haven't changed.The cash...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 23.0¢ | $74.06K | 320.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 102830 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 703 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |